Cite
Rugolo F, Bazan NG, Calandria J, et al. The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome. Oncogene. 2021;40(38):5741-5751doi: 10.1038/s41388-021-01959-3.
Rugolo, F., Bazan, N. G., Calandria, J., Jun, B., Raschellà, G., Melino, G., & Agostini, M. (2021). The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome. Oncogene, 40(38), 5741-5751. https://doi.org/10.1038/s41388-021-01959-3
Rugolo, Francesco, et al. "The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome." Oncogene vol. 40,38 (2021): 5741-5751. doi: https://doi.org/10.1038/s41388-021-01959-3
Rugolo F, Bazan NG, Calandria J, Jun B, Raschellà G, Melino G, Agostini M. The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome. Oncogene. 2021 Sep;40(38):5741-5751. doi: 10.1038/s41388-021-01959-3. Epub 2021 Jul 31. PMID: 34333551.
Copy
Download .nbib